EchoCath gains broader patent for Doppler-transducer:
This article was originally published in Clinica
Executive Summary
EchoCath has received a second US patent for its diffracting Doppler-transducers. The new patent means the company's ultrasonic transducers can monitor and measure the amount of blood flow as well as blood pressure, says executive vice-president David Vilkomerson.